NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NINDS E-206-2000-0-US-02 Method of Increasing Distribution of Therapeutic Agents US ORD 09/999,203 Abandoned
NIAID E-017-2001-0-JP-06 Monoclonal Antibodies Specific for the E2 Glycoprotein of Hepatitis C Virus and Their Use in the Diagnosis, Treatment, and Prevention of Hepatitis C JP National Stage 2002-556628 Abandoned
NIAID E-017-2001-0-EP-05 Monoclonal Antibodies Specific for the E2 Glycoprotein of Hepatitis C Virus and Their Use in the Diagnosis, Treatment, and Prevention of .. EP National Stage 01989143.1 Abandoned
NCI E-124-2001-0-US-01 The Identification of A Modified (Agonist) T-Cell Epitope of The Human Prostate-Specific Antigen (PSA) That Can Enhance The... US 60/334,669 Abandoned
NCI E-123-2001-0-US-01 Pox Viral Vectors for Expressing Human Agonist CTL Epitopes of Prostate-Specific Antigen, And Usea thereof . US 60/334,575 Abandoned
NIDDK E-026-2002-0-US-01 P2X7 Receptor Antagonists US 60/334,130 Abandoned
NCI E-268-1997-4-US-01 MUCOSAL CYTOTOXIC T LYMPHOCYTE RESPONSES US 60/334,498 Abandoned
NIAID E-017-2001-0-CA-04 Monoclonal Antibodies Specific for the E2 Glycoprotein of Hepatitis C Virus and Their Use in the Diagnosis, Treatment, and Prevention of Hepatitis C. CA National Stage 2429946 Abandoned
NIEHS E-265-1998-0-PCT-02 Identification of Compounds That Potentiate The Activity of Muscarinic Potassium Channels PCT PCT PCT/US01/44727 Expired
NIAID E-099-1999-1-BR-03 Use of Recombinant Parainfluenza Viruses (PIV's) as Vectors To Protect Against Infection and Disease Caused By PIV and Other Human Pathogens BR National Stage PI0105530-5 Abandoned
NIAID E-280-2001-0-US-01 Recovery of Recombinant Human Parainfluenza Virus Type 1 (HPIV1) From cDNA and Use of Recombinant HPIV1 as Vaccines And Vectors to ... US 60/331,961 Abandoned
NCI E-079-1999-3-AU-05 METHODS,DEVICES, ARRAYS AND KITS FOR DETECTING AND ANALYZING BIOMOLECULES AU National Stage 2002243236 Expired
NCI E-139-1999-0-US-07 Anti-mesothelin antibodies having high binding affinity US ORD 09/979,539 7081518 Expired PDF
NCI E-143-1996-0-US-04 NOVEL LIPOSOME COMPLEXES FOR INCREASED SYSTEMIC DELIVERY US CON 09/991,028 6770291 Expired PDF
NICHD E-043-1999-0-NZ-05 Utergolobin In The Treatment Of IgA Mediated Autoimmune Disorders NZ National Stage 515588 Expired
NCI E-079-1999-3-PCT-01 METHODS AND ARRAYS FOR DETECTING BIOMOLECULES PCT PCT COMB PCT/US2001/044009 Expired
NCI E-079-1999-3-JP-02 Methods, Devices, Arrays and Kits for Detecting and Analyzing Biomolecules JP National Stage 2002-549932 Abandoned
NCI E-079-1999-3-EP-06 Methods, Devices, Arrays and Kits for Detecting and Analyzing Biomolecules EP National Stage 01989119.1 Expired
CC E-013-1999-0-US-03 Magnetic Resonance Tracking of Magnetically Labeled Cells US National Stage 09/979,464 Abandoned
NCI E-079-1999-3-CA-04 METHODS, DEVICES, ARRAYS AND KITS FOR DETECTING AND ANALYZING BIOMOLECULES CA National Stage 2428441 Abandoned
NCI E-024-2002-0-PCT-01 Methods and Compositions of Defensin-Antigen Fusion Proteins and Chemokine-Antigen Fusion Proteins as Vaccines for Tumors and Viral Infection PCT PCT PCT/US01/43830 Abandoned
NCI E-146-1999-0-PCT-02 Reduction of the Nonspecific Animal Toxicity of Immunotoxin by Mutat- ing the framework regions of the Fv to Lower the Isoelectic Point PCT PCT PCT/US01/43602 Expired
NCI E-158-2002-0-US-01 A Method to Screen Drug Libraries to Identify Drugs that Specifically Interact With Identified Proteins US 60/332,443 Abandoned
NCI E-158-2000-0-US-01 A Rev Tat Nef (Retinef) Chimeric Protein as a Component of an HIV-I Vaccine. US 60/332,433 Abandoned
NICHD E-113-1999-0-CA-06 Sol Fusin: Use of GP64-6HIS To Catalyze Membrane Fusion CA National Stage 2429138 Abandoned
NICHD E-113-1999-0-AU-05 Sol Fusin: Use of GP64-6HIS To Catalyze Membrane Fusion AU National Stage 2002236526 Abandoned
NCI E-021-1996-0-US-05 METHODS AND COMPOSITIONS FOR MONITORING DNA BINDING MOLECULES IN LIVING CELLS US DIV 10/001,486 7312032 Expired PDF
NICHD E-192-1999-0-US-07 Determination of an Empirical Statistical Distribution of the Diffusion Tensor in MRI US National Stage 09/979,013 6845342 Expired PDF
NIAID E-148-1999-0-NZ-11 TREATMENT OF FIBROSIS BY ANTAGONISM OF IL-13 and IL-13 RECEPTOR CHAINS NZ National Stage 515464 Expired
NICHD E-113-1999-0-PCT-02 Sol Fusin: Use of GP64-6HIS To Catalyze Membrane Fusion PCT PCT PCT/US01/44909 Expired
NICHD E-113-1999-0-EP-04 Sol Fusin: Use of GP64-6HIS To Catalyze Membrane Fusion EP National Stage 01986058.4 Abandoned
NIMH E-088-1998-0-NZ-03 Strains of Bacteriophage Useful for Rescuing Patients Infected With Vancomycin-Resistant Enterococcus Faecium NZ National Stage 515506 Abandoned
NIEHS E-270-1999-0-US-02 Methods For The Identification of Textual and Physical Structured Query Fragments For The Analysis of Textual and Biopolymer Information US ORD 09/991,013 Abandoned
NICHD E-068-1999-0-US-06 Universal Protein Array US National Stage 09/936,005 Abandoned
NCI E-005-2002-0-US-01 Discovery of New Gene Expressed in Prostate Cancer US 60/336,308 Abandoned
NCI E-181-1999-0-US-05 Combined Growth Factor-Deleted and Thymidine Kinase-Deleted Vaccinia Virus Vector US National Stage 09/991,721 7208313 Expired PDF
NCI E-091-2007-1-US-06 Variant of LAV viruses US CON 09/986,799 6951648 Expired PDF
NCI E-036-1999-0-US-03 Thiazepine Inhibitors of HIV-1 Integrase US National Stage 10/009,210 7015212 Abandoned PDF
NCI E-424-1987-0-US-05 Neutrophil Chemotactic Factor (As Amended) [IL-8;NCF;MDNCF] US DIV 10/037,218 6475741 Expired PDF
NHLBI E-325-2001-0-US-01 Production of Adeno-Associated Virus in Insect Cells US ORD 09/986,618 Abandoned
NICHD E-023-2002-0-US-01 Methods for Preparing Bacillus Anthracis Protective Antigen For Use In Vaccines (including use of BH445) US 60/344,505 Abandoned
NIAID E-025-2002-0-US-01 Expression, Purification And Efficacy testing of Synthetic Plasmodium Falciparum Apical Membrane Antigen 1 Expressed in Pichia Pastoris US 60/344,752 Abandoned
NIAID E-278-2001-0-US-01 Hepatitis E Virus Clones And Methods of Their Use US 60/350,122 Abandoned
NIAID E-052-2004-0-US-01 Synthetic Genes For Malarial Proteins And Methods Of Use US 60/345,051 Abandoned
NIAAA E-051-2004-0-US-01 Abstracts US 60/344,979 Abandoned
NIAID E-050-2004-0-US-01 Immunogenic Anti-plasmodium Compositions And Method Of Use US 60/331,201 Abandoned
NIAID E-049-1998-0-AU-10 3'GENOMIC PROMOTER REGION AND POLYMERASE GENE MUTATIONS RESPONSIBLE FOR ATTENUATION IN VIRUSES OF THE ORDER DESIGNATED MONONEGAVIRALES AU DIV 89330/01 Abandoned
NCI E-142-1999-0-US-03 A Kit For Determining DNA Double-Stranded Breaks With Anti-y-H2A Antibodies US DIV 10/045,720 6884873 Expired PDF
NINDS E-132-1996-0-US-04 IMMUNOTOXIN (MAB-RICIN) FOR THE TREATMENT OF FOCAL MOVEMENT DISORDERS US CON 10/005,512 6780413 Abandoned PDF
NCI E-271-1998-0-US-07 Methods for Treating Tumors Using Antiangiogenic Compounds US National Stage 10/031,008 Abandoned